Quick Answer
Modular Medical, Inc. reported R&D Expense of $14.70 million for fiscal year 2025.
Modular Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $14.70M | +14.1% |
| 2024 | $12.88M | +42.1% |
| 2023 | $9.06M | +17.2% |
| 2022 | $7.73M | +89.3% |
| 2021 | $4.08M | +34.6% |
| 2020 | $3.03M | +61.2% |
| 2019 | $1.88M | +465.9% |
| 2018 | $332.6K | — |
| 2017 | $0.00 | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $5.41M | +40.3% | -3.4% |
| September 30, 2025 | $5.59M | +51.1% | +8.9% |
| June 30, 2025 | $5.13M | +60.2% | +33.2% |
| December 31, 2024 | $3.85M | +0.4% | +4.1% |
| September 30, 2024 | $3.70M | +17.2% | +15.5% |
| June 30, 2024 | $3.21M | +15.8% | -16.5% |
| December 31, 2023 | $3.84M | +74.7% | +21.5% |
| September 30, 2023 | $3.16M | +32.5% | +14.1% |
- Modular Medical, Inc. showed an increase of +14.1% in R&D Expense compared to the prior fiscal year.
- The most recent figure is from Modular Medical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: